RNA Sequencing Market
According to the USD Analytics published latest research report, the global “RNA Sequencing Market” is expected to grow at a tremendous CAGR of 23.4% during the forecast period 2023-2030.
RNA sequencing is a chain technique that uses next-generation sequencing (NGS) to reveal the presence and quantity of RNA in a biological sample at a particular time, allowing researchers to assess the constantly changing cellular transcriptome. RNA Sequencing, in particular, enhances the capacity to examine alternative gene spliced transcripts, post-transcriptional changes, gene fusion, mutations/SNPs, and changes in gene expression over time, or variations in gene expression in different groups or therapies. The increasing number of RNA sequencing research activities requiring RNA library preparation is expected to boost the RNA Sequencing Market. During the projected period, the rapid development in the precision medicine industry is expected to boost the growth of the RNA Sequencing industry.
Browse Full Report @ https://www.usdanalytics.com/industry-reports/rna-sequencing-market
Advancements in NGS Technologies:
The continuous advancements in NGS technologies, such as improved read lengths, higher throughput, and enhanced accuracy, have significantly contributed to the growth of the RNA sequencing market. These technological innovations have made RNA sequencing more accessible and cost-effective, enabling researchers to perform large-scale transcriptomic studies.
Declining Sequencing Costs:
The decreasing sequencing costs have made RNA sequencing more affordable and accessible to a broader range of researchers. The reduced cost per base pair and the availability of high-throughput sequencers have led to a surge in RNA sequencing experiments across academia and industry.
Growing Application Areas:
RNA sequencing has widespread applications in various fields, including oncology, neuroscience, agriculture, infectious diseases, and developmental biology. The ability to analyze gene expression at a single-cell level has opened new avenues for studying cellular heterogeneity and identifying novel biomarkers and therapeutic targets.
However, a lack of experienced personnel and issues with sequencing data storage limit industry expansion.
Data Management and Analysis: The massive amount of data generated by RNA sequencing poses significant challenges in storage, processing, and analysis. Efficient data management strategies, robust computational infrastructure, and the development of user-friendly analysis tools are essential to overcome these challenges and extract meaningful biological insights.
Standardization and Quality Control: Ensuring the reproducibility and reliability of RNA sequencing results across different laboratories and platforms remains a challenge. Standardizing experimental protocols, benchmarking performance metrics, and implementing quality control measures are crucial to maintaining data integrity and comparability.
Government efforts in population sequencing and growing economies like China and India provide considerable prospects for industry expansion.
The major companies contributing to the global RNA sequencing market growth include Thermo Fischer Scientific Inc., Qiagen, Perkin Elmer, Inc., Agilent Technologies Inc., Illumina, Tecan Genomics Inc., Roche Sequencing Solutions (RSS), GE Healthcare (Cytiva), Bio-Rad Laboratories Inc., Sigma Aldrich.
Download Sample Report @ https://www.usdanalytics.com/sample-request/7420
The global RNA sequencing market is segmented by products and services, technology, application, end user, and region
By-Products and Services:
RNA Sequencing Platforms & Consumables
RNA Sequencing Services
Storage And Management
Sequencing by Synthesis
Ion Semiconductor Sequencing
Single Molecular Real-Time Sequencing
Expression Profiling Analysis
Small RNA Sequencing
De Novo Transcriptome Assembly
Variant Calling & Transcriptome Epigenetics
By End User:
Research And Academia
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Middle East and Africa
In June 2021, QIAGEN N.V. received FDA (U.S. Food and Drug Administration) approval for an expanded scope of applicability for their therascreen KRAS RGQ PCR (Polymerase Chain Reaction) Kit. The latest regulatory approval permits it to be used as a companion diagnostic in conjunction with Amgen’s AMGN newly-approved lung cancer targeted medicine LUMAKRASTM (sotorasib). Following the endorsement, QIAGEN also immediately launched this expanded scope of companion diagnostic (CDx) claims for the therascreen KRAS Kit.
PerkinElmer, Inc. announced the release of two Research Use Only (RUO) solutions in March 2021: the PKampTM VariantDetectTM SARS-CoV-2 RT-PCR Assay and the Next Generation Sequencing-based NEXTFLEX® Variant-SeqTM SARS-CoV-2 Kit. Using nucleic acid isolated from previously positive samples, scientists may use these tests to identify genomic alterations associated with SARS-CoV-2 variations. The U.S. Food and Drug Administration (FDA) has warned clinical labs and healthcare about SARS-CoV-2 viral alterations.
Cell And Gene Therapy Clinical Trials Market Size, Share, Trends, Growth Outlook and Opportunities to 2030-by Phase (Phase I, Phase II, Phase III, Phase IV), by Indication (Oncology, Cardiology, CNS, Musculoskeletal, Infectious Diseases, Dermatology, Endocrine, Metabolic, Genetic, Immunology & Inflammation, Ophthalmology, Hematology, Gastroenterology, Others), and Companies Report
Plasmid DNA Contract Manufacturing Market Size, Share, Trends, Growth Outlook and Opportunities to 2030-by Application (Cell and Gene Therapy, Immunotherapy, Others), by Therapeutic Area (Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases, Others), by End-Use (Pharmaceutical and Biotechnology Companies, Research Institutes), and Companies Report
Women’s Health Diagnostics Market Insights, 2023- Forecasts and Opportunities of Breast Cancer Diagnostics, Infectious Disease Testing, STI Testing, Cervical and Ovarian Cancer Diagnostics, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy and Fertility Diagnosis, Other Diagnostics across hospitals and clinics, diagnostics and imaging centers, and home care, companies and countries to 2030
Company Name: USD Analytics
Contact Person: Harry James
Email: Send Email